Cargando…

Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studies

BACKGROUND: The effect of glucagon-like peptide-1(GLP-1) receptor agonists on heart failure remains uncertain. We therefore conducted a systematic review to assess the possible impact of GLP-1 agonists on heart failure or hospitalization for heart failure in patients with type 2 diabetes. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ling, Li, Sheyu, Liu, Jiali, Deng, Ke, Busse, Jason W., Vandvik, Per Olav, Wong, Evelyn, Sohani, Zahra N., Bala, Malgorzata M., Rios, Lorena P., Malaga, German, Ebrahim, Shanil, Shen, Jiantong, Zhang, Longhao, Zhao, Pujing, Chen, Qunfei, Wang, Yingqiang, Guyatt, Gordon H., Sun, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863354/ https://www.ncbi.nlm.nih.gov/pubmed/27169565 http://dx.doi.org/10.1186/s12872-016-0260-0

Ejemplares similares

Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
por: Li, Ling, et al.
Publicado: (2016)

Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies
por: Li, Ling, et al.
Publicado: (2014)

Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis
por: Liu, Jiali, et al.
Publicado: (2017)

Living cumulative network meta-analysis to reduce waste in research: A paradigmatic shift for systematic reviews?
por: Vandvik, Per Olav, et al.
Publicado: (2016)

The Effects of Clinical Decision Support Systems on Medication Safety: An Overview
por: Jia, Pengli, et al.
Publicado: (2016)

Trustworthy guidelines – excellent; customized care tools – even better
por: Elwyn, Glyn, et al.
Publicado: (2015)

Handling trial participants with missing outcome data when conducting a meta-analysis: a systematic survey of proposed approaches
por: Akl, Elie A., et al.
Publicado: (2015)

Comparison of the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Metabolic Associated Fatty Liver Disease: Updated Systematic Review and Meta-Analysis
por: Dai, Yuzhao, et al.
Publicado: (2021)

Reporting missing participant data in randomised trials: systematic survey of the methodological literature and a proposed guide
por: Akl, Elie A, et al.
Publicado: (2015)

An Evaluation of the Effects of Human Factors and Ergonomics on Health Care and Patient Safety Practices: A Systematic Review
por: Mao, Xuanyue, et al.
Publicado: (2015)

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
por: Palmer, Suetonia C, et al.
Publicado: (2021)

Opioids for chronic non-cancer pain: a protocol for a systematic review of randomized controlled trials
por: Busse, Jason W, et al.
Publicado: (2013)

WHO Living Guidelines on antivirals for COVID-19 are evidence-based
por: Owen, Andrew, et al.
Publicado: (2023)

The molecular pharmacology of glucagon agonists in diabetes and obesity
por: Novikoff, Aaron, et al.
Publicado: (2023)

Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review
por: González-González, José Gerardo, et al.
Publicado: (2021)

Correction: Association of Psychotherapy with Disability Benefit Claim Closure among Patients Disabled Due to Depression
por: Ebrahim, Shanil, et al.
Publicado: (2014)

Association of Psychotherapy with Disability Benefit Claim Closure among Patients Disabled Due to Depression
por: Ebrahim, Shanil, et al.
Publicado: (2013)

Impact of missing participant data for dichotomous outcomes on pooled effect estimates in systematic reviews: a protocol for a methodological study
por: Akl, Elie A, et al.
Publicado: (2014)

Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials
por: Sun, Xin, et al.
Publicado: (2009)

Safety of ezetimibe in lipid-lowering treatment: systematic review and meta-analysis of randomised controlled trials and cohort studies
por: Wang, Yang, et al.
Publicado: (2022)

Return to Work Coordination Programmes for Work Disability: A Meta-Analysis of Randomised Controlled Trials
por: Schandelmaier, Stefan, et al.
Publicado: (2012)

Erratum to: Aspiration thrombectomy prior to percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis
por: El Dib, Regina, et al.
Publicado: (2016)

Aspiration thrombectomy prior to percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis
por: El Dib, Regina, et al.
Publicado: (2016)

Establishing thresholds for important benefits considering the harms of screening interventions
por: Helsingen, Lise Mørkved, et al.
Publicado: (2020)

The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review
por: Sun, Xin, et al.
Publicado: (2011)

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
por: Kang, Yu Mi, et al.
Publicado: (2016)

How glucagon-like peptide 1 receptor agonists work
por: Andreasen, Christine Rode, et al.
Publicado: (2021)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017)

Conformation Transition of Intracellular Part of Glucagon Receptor in Complex With Agonist Glucagon by Conventional and Accelerated Molecular Dynamics Simulations
por: Bai, Qifeng, et al.
Publicado: (2019)

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study
por: Buskermolen, Maaike, et al.
Publicado: (2019)

Decision aids linked to evidence summaries and clinical practice guidelines: results from user-testing in clinical encounters
por: Heen, Anja Fog, et al.
Publicado: (2021)

What is a disease? Perspectives of the public, health professionals and legislators
por: Tikkinen, Kari A O, et al.
Publicado: (2012)

Predictors of health-related quality of life in patients with irritable bowel syndrome. A cross-sectional study in Norway
por: Michalsen, Vilde Lehne, et al.
Publicado: (2015)

Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists
por: Zhang, Yu-Juan, et al.
Publicado: (2013)

Glucagon‐like peptide‐1 receptor agonists and their effects on weight reduction
por: Shin, Shyi‐Jang
Publicado: (2012)

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
por: Hinnen, Deborah
Publicado: (2017)

The potential of glucagon-like peptide-1 receptor agonists in heart failure
por: Kreiner, Frederik Flindt, et al.
Publicado: (2022)

Glucagon-like peptide-1 receptor agonists in patients treated with antipsychotics
por: Delgado, A., et al.
Publicado: (2021)

Glucagon-Like Peptide-1 Receptor Agonists for Chronic Weight Management
por: Wojtara, Magda, et al.
Publicado: (2023)

Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes
por: Eriksson, Olof, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vdfjm5mbab9nl3r8ulcr70pv09